AI MARKET SCANNING

Lineage Cell Therapeutics In

🏛️ NYSE 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.02%
MAX GAP RECORD -9.25%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LCTX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
-2.65%
Mar 05, 2026 Earnings Release 2026-03-05 (AFTER CLOSE)
+5.43%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-9.25%
Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE)
-3.96%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
+0.00%
Mar 10, 2025 Earnings Release 2025-03-10 (AFTER CLOSE)
+1.89%
Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE)
+5.62%
Aug 08, 2024 Earnings Release 2024-08-08 (AFTER CLOSE)
+3.41%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.1%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LCTX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗